Skip to main content

On the Development of Apoprotein and Lipid Levels throughout Childhood

  • Chapter
Lipid Metabolism and Its Pathology

Abstract

Epidemiologic and genetic studies on the evolution of cardiovascular disease in man have repeatedly supported the importance of plasma cholesterol levels in the pathogenesis of coronary atherosclerosis (1–4). These studies also emphasize the importance of distinguishing the cholesterol content of the lipoprotein fractions very low density (VLDL), low density (LDL) and high density lipoproteins (HDL). A close correlation between increased levels of LDL known to contain the major part of the transported cholesterol, and the risk of developing coronary atherosclerosis was found (2,5). HDL, on the other hand, appeared to be negatively correlated with the occurrence of coronary heart disease (6–9).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. McGee, D., and T. Gordon. April 1976. The Framingham Study: the results of the Framingham Study applied to four other U.S.-based epidemiologic studies of cardiovascular disease. Section 31, DHEW Public No. (NIH) 76-1083

    Google Scholar 

  2. Kannel, W.,B. W.P. Castelli, T. Gordon, and P. McNamara. 1971. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann. Intern. Med. 74: 1–12.

    PubMed  CAS  Google Scholar 

  3. Keys, A. 1975. Coronary heart disease - the global picture. Atherosclerosis 22: 149–192.

    Article  PubMed  CAS  Google Scholar 

  4. Gordon, T., M. Carcia-Palmieri, A. Kagan, W.B. Kannel, and Scherffman, J. 1974. Differences in coronary heart disease in Framingham, Honolulu and Puerto Rico. J. Chronic. Dis. 27: 329–344.

    Article  PubMed  CAS  Google Scholar 

  5. Walton, K.W . 1975. Pathogenic mechanism in atherosclerosis. Amer. J. Cardiol. 35: 542–558.

    Article  PubMed  CAS  Google Scholar 

  6. Castelli, W.P., J.T. Doyle, T. Gordon, C.G. Hames, M.C. Hjortland, S.B. Hulley. A. Kagan, and W.J. Zukel, 1977. HDL-cholesterol and other lipids in coronary heart disease. Circulation 55: 767–772.

    PubMed  CAS  Google Scholar 

  7. Gordon, T., W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Amer. J. Med. 62: 707-714.

    Google Scholar 

  8. Miller, N.E., O.H. Forde, D.S. Thelle, and O.D. Mjos. 1977. The Tromsø heart-study- High-density lipoprotein and coronary heart-disease. A prospective case-control study. Lancet i: 965–967

    Article  Google Scholar 

  9. Salel, A.F., A. Fong, R. Zelis, R.R. Miller, N.O. Borhani, and D.T. Mason. 1977. Accuracy of numerical coronary profile. Correlation of risk factors with ar. teriographically documented severity of atherosclerosis. New Engl. J. Med. 296: 1447–1450.

    Article  PubMed  CAS  Google Scholar 

  10. Levine, J., S. Morgenstern, and D. VlasteTica. 1967. Direct Liebermann-Burchard method for serum cholesterol. Technicon Symp. 1: 25.

    CAS  Google Scholar 

  11. Burstein, M., and H.R. Scholnik. 1971. Isolation of lipoproteins from human serum by precipitation with polyanions and divalent cations. Prot. Biol. Fluids 19: 21–27.

    CAS  Google Scholar 

  12. Riesen, W.F., R.C. Mordasini, and G.W. Middelhoff. 1978. Quantitation of the two major apoproteins of human high density lipoproteins by solid phase radioimmunoassays. FEBS letters 91: 35–39.

    Article  PubMed  CAS  Google Scholar 

  13. Mordasini, R., and W.F. Riesen. 1980. Electroimmunoassay and radioimmunoassay for the quantitation of high density apolipoproteins A-I and A-II. J. Clin. Chem. Clin. Biochem. J. Clin. Chem. Clin. Biochem. 18: 917–920.

    CAS  Google Scholar 

  14. Rifkind, B.M., I. Tamir, G. Heiss5 R.B. Wallace, and H.A. Tyroler. 1979. Distribution of high density and other lipoproteins in selected LRC prevalence study populations: a brief survey. Lipids 14: 105–112.

    Article  PubMed  CAS  Google Scholar 

  15. Stein, Y., M.C. Glangeau, M. Fainaru, and O. Stein. 1975. The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high density apolipoprotein. Biophys. Acta 380: 106–118.

    CAS  Google Scholar 

  16. Carew, T.E., S.B. Hayes, F. Koshinsky5 P. Steinberg. 1976. A mechanism by which high density lipoproteins may slow the atherogenic process. Lancet: 1315–1317.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Plenum Press, New York

About this chapter

Cite this chapter

Riesen, W.F., Mordasini, R.C., Sepulcri, F.D., Oetliker, O.H. (1985). On the Development of Apoprotein and Lipid Levels throughout Childhood. In: Halpern, M.J. (eds) Lipid Metabolism and Its Pathology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2445-4_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2445-4_26

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9486-3

  • Online ISBN: 978-1-4613-2445-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics